AFC-HD AMS Life Science Co., Ltd. (TYO:2927)

AFC-HD AMS Life Science Revenue

In the fiscal year ending August 31, 2026, AFC-HD AMS Life Science had annual revenue of 34.32B JPY with 5.11% growth. AFC-HD AMS Life Science had revenue of 9.05B in the quarter ending August 31, 2026, with 14.23% growth. That makes AFC-HD AMS Life Science the 16,876th largest company in the world by revenue and 1,835th in Japan.

• Revenue: 34.32B
• Revenue Growth: +5.11%
• P/S Ratio: 0.35
• Revenue / Employee: 34.05M
• Employees: 1,008
• Market Cap: 12.01B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Healthcare Business 19.04B 57.8%
• Department Store Business 4.62B 14.0%
• Real Estate Trust Business 2.71B 8.2%
• Pharmaceuticals Business 2.48B 7.5%
• Catering Business 2.41B 7.3%
• Others Business 1.66B 5.1%

By Geography

Chart

• Japan 28.03B 85.8%
• Asia (Excluding Japan) 4.62B 14.1%
• Others 7.66M 0.0%

Fiscal year ended Aug 31, 2025 See the full AFC-HD AMS Life Science breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Aug 31, 2026	34.32B	1.67B	5.11%
Aug 31, 2025	32.66B	2.47B	8.18%
Aug 31, 2024	30.19B	4.61B	18.01%
Aug 31, 2023	25.58B	2.58B	11.23%
Aug 31, 2022	23.00B	629.00M	2.81%

Data Source: S&P Global Market Intelligence Last updated: Oct 15, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 6, 2026

Data Sources Report a data error